Agilent Technologies introduced its new S540MD slide scanner on January 23, 2026, offering a high‑throughput whole‑slide imaging solution that can process up to 540 glass slides in a single run. The scanner is available for purchase in key European markets—including Germany, France, Belgium, Spain, Austria, Luxembourg, Italy, the United Kingdom, and Switzerland—and is designed for continuous loading and compatibility with standard rack configurations, allowing laboratories to maintain high sample throughput without manual intervention.
The S540MD incorporates automated scanning modes and AI‑assisted tissue detection, enabling rapid identification of areas of interest and reducing the time pathologists spend on manual review. Its continuous‑loading capability and 540‑slide capacity make it one of the fastest scanners on the market, while the AI features help laboratories achieve consistent image quality and streamline workflow integration with existing digital pathology platforms.
Agilent’s partnership with Hamamatsu, the original developer of the NanoZoomer S540MD, positions the company to offer a fully integrated digital pathology ecosystem that includes scanners, image management systems, and AI analysis algorithms. The scanner meets European regulatory requirements, being compliant with IVDR, UK MDR2002, and IvDO, which facilitates adoption in regulated clinical settings. The launch expands Agilent’s product line from staining and AI decision support to complete slide imaging, strengthening its competitive stance in a market projected to reach USD 2.75 billion by 2030.
The digital pathology market is growing rapidly, driven by the need for scalable diagnostic solutions in high‑volume laboratories. Agilent’s fiscal 2025 revenue of $6.95 billion and Q4 2025 revenue of $1.86 billion underscore the company’s solid financial foundation, while the new scanner is expected to contribute to future revenue growth by capturing a share of the expanding demand for high‑throughput imaging. The launch aligns with Agilent’s broader strategy to deepen its presence in the life‑science diagnostics space and to leverage its expertise in AI and imaging technology.
"The introduction of the Agilent S540MD Slide Scanner System marks an important advancement in our commitment to equip pathology laboratories with advanced digital technologies," said Nina Green, vice president and general manager of Agilent’s clinical diagnostics division. The new scanner is expected to accelerate the adoption of digital pathology workflows across Europe and support the company’s goal of delivering end‑to‑end solutions that improve diagnostic efficiency and accuracy.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.